Lucentis
As listed in the register: Lucentis, Injektionslösung zur intravitrealen Anwendung in Durchstechflasche
·
- Prescription only
- Eyes and ears
- Active substance
- Ranibizumabum
- Used in
- Eyes and ears
- Made by
- Novartis Pharma Schweiz AG
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- exsudative altersbezogene Makuladegeneration, Visusverlust duch diabetisches Makulaödem, durch Makulaödem infolge eines retinalen Venenverschlusses und durch choroidale Neovaskularisation infolge pathologischer Myopie, aktive, den Visus beeinträchtigende choroidale Neovaskularisation, mässig schwere bis schwere NPDR bzw PDR, Frühgeborenen-Retinopathie
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Novartis Pharma Schweiz AG |
|---|---|
| Active substance | Ranibizumabum |
| Used in | Eyes and ears |
| Classification | S01LA04 · Eyes and ears |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Lucentis, Injektionslösung zur intravitrealen Anwendung in Durchstechflasche |
| Packs | 0,23 ml Durchstechflasche(n) · 0,23 ml Durchstechflasche(n) · 0.23 ml Durchstechflasche(n) |
| Zulassungsnummer | 57664 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.
Other strengths and forms
2 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
- 2 products
—2
— · 2 companies
- Novartis Pharma Schweiz AG · this page
- Novartis Pharma Schweiz AG
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.